1,25‐Dihydroxyvitamin D3 Regulates the Synthesis of γ‐Glutamyl Transpeptidase and Glutathione Levels in Rat Primary Astrocytes

  title={1,25‐Dihydroxyvitamin D3 Regulates the Synthesis of $\gamma$‐Glutamyl Transpeptidase and Glutathione Levels in Rat Primary Astrocytes},
  author={Emmanuel Garçion and Laurence Sindji and G{\'e}rard Leblondel and Philippe Brachet and Françoise Darcy},
  journal={Journal of Neurochemistry},
Abstract : Astrocytes play a pivotal role in CNS detoxification pathways, where glutathione (GSH) is involved in the elimination of oxygen and nitrogen reactive species such as nitric oxide. We have previously demonstrated that the specific activity of γ‐glutamyl transpeptidase (γ‐GT), an enzyme of central significance in GSH metabolism, is regulated in vivo in astrocytes by 1,25‐dihydroxyvitamin D3 (1,25‐D3). The aim of the present work was to investigate, in primary cultures of newborn rat… 

Thyroid hormone stimulates γ‐glutamyl transpeptidase in the developing rat cerebra and in astroglial cultures

The activation of γGT by TH may be conducive to GSH synthesis in neurons and their protection from oxidative stress, and the products ofγGT reaction are putative precursors for neuronal GSH.

Nrf2‐dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis

It is demonstrated that total GSH levels are reduced in EAE, suggesting an impaired synthesis and that translation of this important transcription factor and/or other still unidentified post‐translational processes are altered in Eae.

1α,25-Dihydroxyvitamin D3 enhances γ-glutamyl transpeptidase activity in LLC-PK1 porcine kidney epithelial cells.

Investigation of the effect of derivatives of vitamin D3 on GGT activity in LLC-PK1 porcine renal tubular epithelial cells found that the expression of GGT is not entirely constitutive in the kidney, but is altered under certain conditions, including under hormonal regulation.

Protective role of 1α, 25‐dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells

The results showed that 1,25‐VD can protect nonmalignant prostate cells from oxidative stress‐induced cell death by elimination of ROS‐induced cellular injuries through transcriptional activation of G6PD activity, which strengthens its roles in cancer chemoprevention and adds to a growing list of beneficial effects of vitamin D against cancer.

1α,25‐dihydroxyvitamin D3 attenuates cyanide‐induced neurotoxicity by inhibiting uncoupling protein‐2 up‐regulation

It was concluded that VD3 blocks Wy14,643 enhancement of cyanide neurotoxicity by suppressing the redox‐mediated transcriptional up‐regulation of UCP‐2, resulting in reduced mitochondrial proton leak and stabilization of mitochondrial function.

1,25-Dihydroxyvitamin D3 and its analogues increase catalase at the mRNA, protein and activity level in a canine transitional carcinoma cell line.

Global gene expression analysis identified the involvement of mitogen-activated protein kinase (MAPK) signalling in cbTCC's response to calcitriol and seocalcitol treatment as well as the effects of antioxidant enzyme gene expression, protein expression and activity.

Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25‐dihydroxyvitamin D3

The present study investigates the presence of vitamin D receptor (VDR) in cells of the rat oligodendrocyte (OL) lineage and finds that unlike retinoic acid (RA), thyroid hormone, 1,25‐(OH)2D3 has no regulatory action on the synthesis of myelin proteins.



1,25-dihydroxyvitamin D3 regulates γ-glutamyl transpeptidase activity in rat brain

γ‐glutamyl transpeptidase (γ‐GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents

Investigation into the role of γ‐GT in the extracellular metabolism of GSH indicates that resistant tumor cells metabolize two‐fold more GSH than do sensitive cells and that such metabolism results in a similar difference in the intracellular concentration of cysteine.

Synthesis of 1,25‐dihydroxyvitamin D3 by rat brain macrophages in vitro

The results support the emerging concept that the brain constitutes a target tissue for vitamin D metabolites, and raise the possibility that activation of microglial cells in vivo may be followed by an increase in the level of 1,25‐(OH)2D3 in the central nervous system (CNS).

1α, 25 dihydroxyvitamin D3‐dependent up‐regulation of calcium‐binding proteins in motoneuron cells

The data suggest that analogs of 1,25 dihydroxyvitamin D3 may be useful tools in enhancing the expression of calcium binding proteins in the motor system and may have possible therapeutic value in neurodegenerative disease.

Vitamin E, Ascorbate, Glutathione, Glutathicne Disulfide, and Enzymes of Glutathione Metabolism in Cultures of Chick Astrocytes and Neurons: Evidence that Astrocytes Play an Important Role in Antioxidative Processes in the Brain

The data suggest that astrocytes are resistant to reactive oxygen species (and potentially toxic xenobiotics) and may play a protective role in the brain and provide insights into the design of therapeutic strategies to combat oxidative and xenobiotic stresses.

1,25‐Dihydroxyvitamin D3 regulates NT‐3, NT‐4 but not BDNF mRNA in astrocytes

It is suggested that 1,25-dihydroxyvitamin D3 may participate in the expression of NGF, NT-3, and NT-4 in the central nervous system.

1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei.

The results suggest that 1,25-(OH)2D3 effects cholinergic activity in several discrete brain regions and may play a role in the neuroendocrine regulation of certain aspects of anterior pituitary gland function.

1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells.

gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.

Investigation into the role of gamma-GT in the extracellular metabolism of GSH indicates that resistant tumor cells metabolize two-fold more GSH than do sensitive cells and that such metabolism results in a similar difference in the intracellular concentration of cysteine.